{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:40:03Z","timestamp":1750534803630,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Progressive supranuclear palsy (PSP) is the most prevalent form of degenerative atypical parkinsonism. Clinical manifestations of PSP commonly encompass deficits in vertical gaze, postural stability, akinesia, and cognitive impairment. The characteristic metabolic pattern observed in PSP through FDG PET displays hypometabolism in the midbrain, striatum, thalamus, and frontal lobe. However, visual interpretation of midbrain hypometabolism poses challenges. In this report, we aim to elucidate a novel observation termed the \u201closs of Mickey Mouse ears\u2019 sign,\u201d which signifies midbrain hypometabolism as detected through visual assessment of FDG PET images.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005229","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T20:01:58Z","timestamp":1712779318000},"page":"551-553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Loss of Mickey Mouse Ears\u2019 Sign in Progressive Supranuclear Palsy"],"prefix":"10.1097","volume":"49","author":[{"given":"Tsz-Kit","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Man","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","year":"2017","journal-title":"Mov Disord"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fneur.2020.00180","article-title":"Progressive supranuclear palsy\u2013parkinsonism predominant (PSP-P)\u2014a clinical challenge at the boundaries of PSP and Parkinson's disease (PD)","volume":"11","year":"2020","journal-title":"Front Neurol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: pathology and genetics","volume":"17","year":"2007","journal-title":"Brain Pathol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","article-title":"18F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0404.2004.00293.x","article-title":"Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy","volume":"110","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00259-018-4031-2","article-title":"Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00259-018-4030-3","article-title":"Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.parkreldis.2013.10.023","article-title":"The pimple sign of progressive supranuclear palsy syndrome","volume":"20","year":"2014","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:37Z","timestamp":1750532737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005229","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}